ADIPOQ and fibrosis: Since plasma levels of adiponectin and adiponectin exposure over time did not correlate with kidney disease severity (percentage of fibrosis and KIM-1 expression) in the present study it is unlikely that adiponectin plays a causal role under the experimental conditions applied herein.